PPD

JULY 13, 2023

Site and patient recruitment vendors are vital in supporting clinical trial operations across all phases and therapeutic areas. Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

H1 Blog

JULY 30, 2024

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.” billion and taking upwards of 15 years.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

biobide

FEBRUARY 2, 2024

This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes. This treatment was developed by performing a chemical screening on zebrafish.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

H1 Blog

DECEMBER 11, 2024

Drug Policy There will be significant changes in clinical trials & drug development due to the Inflation Reduction Act. As pharmaceutical companies shift their focus toward fewer, high-value therapeutic areas in light of the IRAs drug price negotiations, the overall number of clinical trials will go down.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. She has held leadership positions in Project Management, Technical Operations, and Business Development.

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

Predictive Oncology

FEBRUARY 7, 2023

“We’re providing that richness of tumor diversity and the population diversity that normally the companies will not be able to see until they are in a clinical trial and [the drug is] challenged against a multitude of different patients.” We can improve on that. We can cut the time. We can cut the cost.”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Altus Drug Development

JUNE 28, 2022

For example, the chemical compound Thalidomide, which was created via drug repurposing, can be used in the treatment of HIV, various forms of cancer, and skin conditions like complications associated with leprosy. Drug repositioning has become a strategic research approach when treating neglected diseases.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

Codon

FEBRUARY 13, 2024

Many pathogenic bacteria have not just developed resistance to the most common drug used to treat them — known as antimicrobial resistance or AMR; they have become multi-drug resistant (MDR), extensively drug-resistant (XDR), or pan-drug resistant (PDR) — the latter meaning they are resistant to every drug we have in the cabinet.

Therapies 137

Therapies Virus DNA Clinical Trials 137

The Pharma Data

OCTOBER 20, 2020

In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. The fund is already starting off with more than $50 million in initial capital.

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

Vial

MARCH 1, 2024

Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. Get in touch to learn how to work together on your next clinical trial.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

The Pharma Data

DECEMBER 30, 2020

Then, in July, after analyzing completed data and with talks with the FDA, they decided they were going to pursue regulatory approval for the drug. In early December 2019, they presented full data at the 12th Clinical Trials on Alzheimer’s Disease (CATD) conference. BioMarin Pharmaceutical’s Roctavian for hemophilia B.

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug & Device Law

SEPTEMBER 1, 2023

We observed oral argument the other day in a case that could have a significant impact on potential liability under California tort law for pharma companies and all other innovators. In the end, counsel urged that imposing undue liability would discourage drug development. In Gilead v. Superior Court , No. A165558 (Cal.

Production 64

Production Marketing Drugs Pharma Companies 64

Drug Target Review

MARCH 13, 2025

Planning the journey from data to deliverables The future of AI-enabled drug development benefits from the continued advancement of multimodality and clinical genomics, with a focus on integration, efficiency and personalisation to transform both care and R&D. Techbio companies have initiated this approach.

Drug Development 59

Drug Development Science Clinical Trials Drugs 59